Compass Pathways is trading 6.75% up at $14.13 after no clear September 2, 2026 company-specific catalyst was identified.
- The latest surfaced disclosures were second-quarter results released August 5 and a September 9 healthcare conference appearance; neither directly explains the pre-market move.
- Broader markets were weaker, so the gain does not clearly track overall sentiment.
- The catalyst remains unclear and should be rechecked for delayed announcements.